ClinicalTrials.Veeva

Menu

Mechanisms and Reversibility of Heart Failure Associated With Diabetes (MRHD)

D

Dr. Peter Swoboda

Status

Completed

Conditions

Type 2 Diabetes

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Patients with diabetes have a higher incidence of heart failure and worse outcomes than normoglycaemic subjects. Basic science research has suggested many mechanisms for this observation including endothelial dysfunction, abnormal calcium handling, fibrosis and activation of the renin-angiotensin-aldosterone system (RAAS), but clinical data are lacking. In this study the investigators will investigate the relationship between diabetes and heart failure by exploring the correlation between microvascular dysfunction and cardiac magnetic resonance (CMR) markers of left ventricular (LV) hypertrophy, cardiac dysfunction and fibrosis. The investigators also propose to see if this relationship is independent of blood pressure and markers of RAAS activity. This could have important clinical ramifications in type 2 diabetes by increasing the indications for treatment with RAAS inhibition or making a case for lower blood pressure targets.

Enrollment

110 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Type 2 diabetes

Exclusion criteria

  • Known cardiac or renal disease
  • Uncontrolled hypertension
  • Treatment with ACEi/ARB
  • Treatment with insulin
  • Contraindication to CMR

Trial design

110 participants in 2 patient groups

Diabetic with nephropathy
Diabetics without nephropathy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems